Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Hydralazine hydrochloride - Generic Drug Details

« Back to Dashboard
Hydralazine hydrochloride is the generic ingredient in twenty-seven branded drugs marketed by Teva, Hetero Labs Ltd Iii, Novartis, Watson Labs, Mutual Pharm, Vangard, X-gen Pharms Inc, Ascot, Mylan, Solopak, Smith And Nephew, Halsey, Impax Labs, Glenmark Pharms Ltd, Frontida Biopharm, Akorn, Abraxis Pharm, Luitpold, Par Pharm, Alkem Labs Ltd, Ivax Sub Teva Pharms, Navinta Llc, West Ward, Upsher-smith Labs, Heritage Pharms Inc, Cadila Pharms Ltd, Tg United Labs, Actavis Elizabeth, Usl Pharma, Quantum Pharmics, Invagen Pharms, Pliva, Strides Pharma, Teva Parenteral, Purepac Pharm, Actavis Grp Ptc, Mylan Institutional, Superpharm, Fresenius Kabi Usa, Sandoz, Vitarine, Solvay, Ivax Pharms, Lederle, Sun Pharm Inds, and Arbor Pharms Llc, and is included in one hundred and eighteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for hydralazine hydrochloride. Forty-one suppliers are listed for this compound.

Summary for Generic Name: hydralazine hydrochloride

Drug Master File Entries: see list19
Suppliers / Packagers: see list41
Bulk Api Vendors: see list64
Clinical Trials: see list1,004
Patent Applications: see list836
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:hydralazine hydrochloride at DailyMed

Pharmacology for Ingredient: hydralazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tg United Labs
hydralazine hydrochloride
TABLET;ORAL088847-001Feb 26, 1985DISCNNoNo► subscribe► subscribe
hydralazine hydrochloride
TABLET;ORAL087908-001May 7, 1982DISCNNoNo► subscribe► subscribe
hydralazine hydrochloride
TABLET;ORAL086088-001Approved Prior to Jan 1, 1982DISCNNoNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.